Assembly biosciences announces the closing and early termination of hart-scott-rodino waiting period for license of microbiome gastrointestinal development programs to allergan – forextv
INDIANAPOLIS, Feb. Webmaster tools submit site 21, 2017 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. Outils webmaster gratuit (NASDAQ: ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome, today announced it has received early termination of the waiting period required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, closed the transaction and received the upfront payment from Allergan plc for the research, development, collaboration and license agreement between the two companies announced on January 9, 2017 ( see 8-K filing dated January 10, 2017).
The agreement provides Allergan with worldwide rights to preclinical compounds from Assembly’s microbiome gastrointestinal development programs, including ABI-M201 and ABI-M301, targeting ulcerative colitis and Crohn’s disease, as well as two additional compounds targeting Irritable Bowel Syndromes.
Assembly Biosciences, Inc. Webmaster tools content keywords is a clinical-stage public biotechnology company developing two innovative platform programs: an HBV program advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and a microbiome program developing novel oral live biotherapeutics designed to address diseases associated with the microbiome.
Webmaster keyword tools Assembly’s HBV program is advancing multiple drug candidates with the aim of increasing cure rates in patients with chronic HBV. Webmaster tools php script The company’s microbiome program consists of a fully integrated platform that includes a robust strain identification and selection process, methods for strain isolation and growth under current Good Manufacturing Practices and a patent-pending delivery system, GEMICEL ®, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. Webmaster tools html Assembly is developing a robust pipeline of product candidates in multiple disease indications. Webmaster tools blogspot For more information, visit www.assemblybio.com.
The information in this press release contains forward-looking statements regarding future events, including statements about the clinical and therapeutic potential of Assembly’s development programs. Webmaster tools add url Certain forward-looking statements may be identified by reference to a future period or periods or by use of forward-looking terminology such as “intends,” “expected” or “developing.” Assembly intends such forward-looking statements to be covered by the safe harbor provisions contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Webmaster tools joomla Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Googlw webmaster tools More information about the risks and uncertainties faced by Assembly are more fully detailed under the heading “Risk Factors” in Assembly’s Annual Report on Form 10-K for the year ended December 31, 2015, and Quarterly Report on Form 10-Q for the quarter ending September 30, 2016 filed with the Securities and Exchange Commission. Webmaster free tools Except as required by law, Assembly assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Risk Disclaimer – By using this web site you agree to its terms and conditions. Webmaster tools reconsideration request Before deciding to invest in foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. Webmaster tools add site The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. Sign in to webmaster tools You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts. What does webmaster tools do Forex (or FX or off-exchange foreign currency futures and options) trading involves substantial risk of loss and is not suitable for every investor. Add site to webmaster tools The value of currencies may fluctuate and investors may lose all or more than their original investments. Webmaster tools online Risks also include, but are not limited to, the potential for changing political and/or economic conditions that may substantially affect the price and/or liquidity of a currency. Webmaster tools test The impact of seasonal and geopolitical events is already factored into market prices. Googlle webmaster tools The leveraged nature of FX trading means that any market movement will have an equally proportional effect on your deposited funds and such may work against you as well as for you. Webmaster tools keyword planner Past results are no indication of future performance. Webmaster tools help Information contained this web site is intended for informational purposes only and was obtained from sources believed to be reliable. Submit webmaster tools Information is in no way guaranteed. Webmaster tools sitemaps No guarantee of any kind is implied or possible where projections of future conditions are attempted.